A clinical study on the Efficacy of TULASI ARKA in Pre-Operative Skin Preparation

A Comparative Clinical Study on the Efficacy of Tulasi Arka and Povidone Iodine in Preoperative Skin Preparation in Perianal Abscess

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021147

Enrollment

Registered

2019-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Surgical Site Preparation with Tulasi Arka: Dose: Quantity sufficient as per the operating site Frequency:Once Route of administration: External application on skin Total duration of t

Eligibility

Inclusion criteria

Inclusion criteria: Perianal abscess

Exclusion criteria

Exclusion criteria: 1.Systemic disorders diabetes mellitus, hypertension, pulmonary tuberculosis 2.Skin diseases. 3.HIV, HBsAg, VDRL 4.History of impaired wound healing.

Design outcomes

Primary

Measure	Time frame
Swab test: Swabs taken before and after the application of test and control drug will be sent to the culture sensitivity and comparedTimepoint: 1 day	—

Secondary

Measure	Time frame
Bacterial LoadTimepoint: 1 Day	—

Countries

India

Contacts

Public ContactDr GOPIKRISHNA B J

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

drgopiboyapati@gmail.com9886360901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026